Indication intelligence, analysis and sector perception

Regulatory Disclosure

May 16, 2013 8:36pm

RegMedinvestore or RMi or its affiliate ScimitarEquity (Scimitar) is an on-line news portal providing analysis for under-followed and small capitalization health science companies.

RMi is a publisher of reviews utilizing the "subsription" compensation model to increase visibility and access for these sector specific companies.

RMi "clearly and prominently" articulates a statement of subscription to recieve these posts, blogs, reviews or prognostications via the world-wide web and our proprietary database to the institutional, advisory and retail investment communities. We do not accept payment of any fees in company stock or any form of security. RegMedinvestors, RMi or its affiliate Scimitar Equity will NOT have any investment banking relationships with any company to maintain our independence and objectivity.

RMi or Scimitar is NOT registered as a securities broker-dealer or an investment advisor either with the SEC or with any state securities regulatory agencies.

RMi or its afilliate Scimitar Equity does NOT and will NOT own any securities related to companies we provide reviews, analysis or develop research products. We prohibit our employees, persons reporting to me from maintaining any financial interest in the securities of any company that we provide reviews ... upon.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.